These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31786812)

  • 21. Optimal clinical management of eye problems: the role of optometrists in managed care plans.
    Soroka M; Krumholz DM; Krasner M; Portello J
    Optometry; 2000 Dec; 71(12):781-90. PubMed ID: 11145303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping human resources for eye health in 21 countries of sub-Saharan Africa: current progress towards VISION 2020.
    Palmer JJ; Chinanayi F; Gilbert A; Pillay D; Fox S; Jaggernath J; Naidoo K; Graham R; Patel D; Blanchet K
    Hum Resour Health; 2014 Aug; 12():44. PubMed ID: 25128163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of clinical techniques relevant for glaucoma assessment by optometrists: concordance with guidelines.
    Jamous KF; Kalloniatis M; Hayen A; Mitchell P; Stapleton FJ; Zangerl B
    Ophthalmic Physiol Opt; 2014 Sep; 34(5):580-91. PubMed ID: 25103462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Australian optometric workforce 2005, analysed by local government areas.
    Kiely PM; Horton P; Chakman J
    Clin Exp Optom; 2007 Mar; 90(2):83-107. PubMed ID: 17311571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Australian optometric workforce 2009.
    Kiely PM; Horton P; Chakman J
    Clin Exp Optom; 2010 Sep; 93(5):330-40. PubMed ID: 20718789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of ocular therapeutic pharmaceutical agents in optometric practice.
    Schmid KL; Schmid LM; Swann PG; Hartley L
    Clin Exp Optom; 2000; 83(1):16-31. PubMed ID: 12472463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to glaucoma case finding as perceived by optometrists in Ireland.
    Barrett C; O'Brien C; Butler JS; Loughman J
    Clin Exp Optom; 2018 Jan; 101(1):90-99. PubMed ID: 28718219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic endorsement enhances compliance with national glaucoma guidelines in Australian and New Zealand optometrists.
    Zangerl B; Hayen A; Mitchell P; Jamous KF; Stapleton F; Kalloniatis M
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):212-24. PubMed ID: 25684127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial.
    Violato M; Dakin H; Chakravarthy U; Reeves BC; Peto T; Hogg RE; Harding SP; Scott LJ; Taylor J; Cappel-Porter H; Mills N; O'Reilly D; Rogers CA; Wordsworth S
    BMJ Open; 2016 Oct; 6(10):e011121. PubMed ID: 27797985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into Australian optometrists' knowledge and attitude towards prescribing blue light-blocking ophthalmic devices.
    Singh S; Anderson AJ; Downie LE
    Ophthalmic Physiol Opt; 2019 May; 39(3):194-204. PubMed ID: 30957274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographics and distribution of the optometry profession in Australia: 2011 to 2019.
    Duffy JF; Kirkman JM; Woods CA; Douglass AG
    Clin Exp Optom; 2023 Nov; 106(8):911-919. PubMed ID: 36191959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health information technology adoption in New Zealand optometric practices.
    Heidarian A; Mason D
    Clin Exp Optom; 2013 Nov; 96(6):557-65. PubMed ID: 24730034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.
    Reeves BC; Scott LJ; Taylor J; Harding SP; Peto T; Muldrew A; Hogg RE; Wordsworth S; Mills N; O'Reilly D; Rogers CA; Chakravarthy U
    BMJ Open; 2016 Jul; 6(7):e010685. PubMed ID: 27401357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Australian optometric workforce 2005.
    Horton P; Kiely PM; Chakman J
    Clin Exp Optom; 2006 Jul; 89(4):229-40. PubMed ID: 16776730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optometrist prescribing of therapeutic agents: findings of the AESOP survey.
    Mason A; Mason J
    Health Policy; 2002 May; 60(2):185-97. PubMed ID: 11897376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supply, distribution, and capacity of optometrists in Indiana.
    Marshall EC
    Optometry; 2000 May; 71(5):301-17. PubMed ID: 10998944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mobility of optometrists practising in Australia in 2005: do optometry graduates move to states without schools of optometry?
    Kiely PM; Horton P
    Clin Exp Optom; 2008 Jan; 91(1):96-102. PubMed ID: 18045255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian optometric and ophthalmologic referral pathways for people with age-related macular degeneration, diabetic retinopathy and glaucoma.
    Jamous KF; Jalbert I; Kalloniatis M; Boon MY
    Clin Exp Optom; 2014 May; 97(3):248-55. PubMed ID: 24400653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optometry Australia Scope of Practice Survey 2015.
    Kiely PM; Cappuccio S; McIntyre E
    Clin Exp Optom; 2017 May; 100(3):260-269. PubMed ID: 28295595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optometry in a hospital setting.
    Soroka M; Feldman L
    J Community Health; 2005 Feb; 30(1):13-22. PubMed ID: 15751596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.